160 related articles for article (PubMed ID: 7523387)
1. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis.
Slungaard A; Key NS
J Biol Chem; 1994 Oct; 269(41):25549-56. PubMed ID: 7523387
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C.
Dudek AZ; Pennell CA; Decker TD; Young TA; Key NS; Slungaard A
J Biol Chem; 1997 Dec; 272(50):31785-92. PubMed ID: 9395524
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
4. Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors.
Yang L; Rezaie AR
Thromb Haemost; 2007 Jun; 97(6):899-906. PubMed ID: 17549291
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 impairs the anticoagulant activity of activated protein C.
Preston RJ; Tran S; Johnson JA; Ní Áinle F; Harmon S; White B; Smith OP; Jenkins PV; Dahlbäck B; O'Donnell JS
J Biol Chem; 2009 Feb; 284(9):5869-75. PubMed ID: 19129181
[TBL] [Abstract][Full Text] [Related]
6. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.
Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M
Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo.
Slungaard A; Fernandez JA; Griffin JH; Key NS; Long JR; Piegors DJ; Lentz SR
Blood; 2003 Jul; 102(1):146-51. PubMed ID: 12609838
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 modulation of the thrombomodulin-protein C system.
Slungaard A
Crit Care Med; 2004 May; 32(5 Suppl):S331-5. PubMed ID: 15118540
[TBL] [Abstract][Full Text] [Related]
9. Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation.
Liu LW; Rezaie AR; Carson CW; Esmon NL; Esmon CT
J Biol Chem; 1994 Apr; 269(16):11807-12. PubMed ID: 8163479
[TBL] [Abstract][Full Text] [Related]
10. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
11. Tryptophans 231 and 234 in protein C report the Ca(2+)-dependent conformational change required for activation by the thrombin-thrombomodulin complex.
Rezaie AR; Esmon CT
Biochemistry; 1995 Sep; 34(38):12221-6. PubMed ID: 7547963
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
[TBL] [Abstract][Full Text] [Related]
13. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
14. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
[TBL] [Abstract][Full Text] [Related]
16. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease.
Slungaard A; Vercellotti GM; Tran T; Gleich GJ; Key NS
J Clin Invest; 1993 Apr; 91(4):1721-30. PubMed ID: 8386194
[TBL] [Abstract][Full Text] [Related]
18. Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin.
Gerlitz B; Grinnell BW
J Biol Chem; 1996 Sep; 271(37):22285-8. PubMed ID: 8798383
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.
Ye J; Rezaie AR; Esmon CT
J Biol Chem; 1994 Jul; 269(27):17965-70. PubMed ID: 8027055
[TBL] [Abstract][Full Text] [Related]
20. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
